Netherlands· NL-716a145ec8bd
Sunmedabon, Combinatieverpakking mifepriston 200 mg tablet en misoprostol 4 x 0,2 mg vaginale tabletten
A misoprostol product containing mifepriston + misoprostol, registered in Netherlands by Sun Pharmaceutical Industries Europe B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Misoprostol is registered in 11 of 19 countries.
Countries holding a registration under ATC G02AD06 (misoprostol), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Misoprostol · ATC G02AD06
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of misoprostol costs, country by country.
Normalised to the WHO defined daily dose (0.2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Misoprostol · price per daily dose (0.2 mg)
USD · FX 28 Sept 2026
- US United States$0.72 (acquisition cost)
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- MIFEPRISTON + MISOPROSTOL
- Manufacturer
- Sun Pharmaceutical Industries Europe B.V.
- Country
- Netherlands (NL)
- ATC code
- G02AD06
- ATC class
- Misoprostol
- Defined daily dose
- 0.2 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id106099
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
245 interactions on record for misoprostol.
Graded by severity as the source publishes them — 10 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Misoprostol · interactions on record
245 records
- 10 moderate
- 6 minor
- 229 info
Most severe, free to view
- Magnesium carbonateA02AA01moderate
- Magnesium oxideA02AA02moderate
- Magnesium hydroxideA02AA04moderate
- Kombinationen von AluminiumsalzenA02AB10moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Misoprostol in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Medabon Combipack
- Romania · Medabon Pachet Combinat
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/afb91418-aed9-4d2f-8baf-d5e4e4b8a19f GET /v1/drugs/afb91418-aed9-4d2f-8baf-d5e4e4b8a19f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik, Vaginaal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h106099_smpc.pdf",
"strength": null,
"atc_label": "Misoprostol#G03XB51 - Mifepristone, combinations",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg106099",
"excipients": [
"CASTOROLIE, GEHYDROGENEERD",
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"HYPROMELLOSE (E 464)",
"MAGNESIUMSTEARAAT (E 470b)",
"MAÏSZETMEEL",
"NATRIUMZETMEELGLYCOLAAT",
"POVIDON K 30 (E 1201)",
"SILICIUMDIOXIDE (E 551)"
],
"substances": [
"MIFEPRISTON",
"MISOPROSTOL"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h106099.pdf",
"authorised_at": "2012/05/09",
"procedure_number": "NL/H/4796/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "106099",
"additional_monitoring": "N"
}See everything about misoprostol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.